These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 157829)
41. Effects of intraventricular injection of Sar1-Ala8-angiotensin II on plasma vasopressin level increased by angiotensin II and by water deprivation in conscious rats. Yamaguchi K; Hama H; Sakaguchi T; Negoro H; Kamoi K Acta Endocrinol (Copenh); 1980 Apr; 93(4):407-12. PubMed ID: 7386111 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of the pressor and aldosterone-releasing effects of angiotensin II. Bumpus FM; Khosla MC Clin Sci Mol Med Suppl; 1975 Jun; 2():15s-18s. PubMed ID: 1077765 [TBL] [Abstract][Full Text] [Related]
43. Agonistic activities of isoleucine8-angiotensin II in man. Kono T; Taniguchi A; Imura H; Oseko F; Khosla MC Endocrinol Jpn; 1985 Oct; 32(5):701-8. PubMed ID: 3912161 [TBL] [Abstract][Full Text] [Related]
44. Cardiovascular effects of microinjection of angiotensin II in the brainstem of renal hypertensive rats. Mosqueda-Garcia R; Tseng CJ; Appalsamy M; Robertson D J Pharmacol Exp Ther; 1990 Oct; 255(1):374-81. PubMed ID: 2213569 [TBL] [Abstract][Full Text] [Related]
46. Effects of central and peripheral angiotensin blockade in hypertensive rats. Mann JF; Phillips MI; Dietz R; Haebara H; Ganten D Am J Physiol; 1978 May; 234(5):H629-37. PubMed ID: 645931 [TBL] [Abstract][Full Text] [Related]
47. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat? Bruner CA; Weaver JM; Fink GD J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220 [TBL] [Abstract][Full Text] [Related]
48. Human aortic smooth muscle cells containing angiotensin II type 1 receptors. Yazawa H; Iida-Kubota E; Honda K Jpn J Pharmacol; 1993 Aug; 62(4):339-43. PubMed ID: 8230860 [TBL] [Abstract][Full Text] [Related]
49. Angiotensin receptors and pressor hyperresponsiveness in renal prehypertensive rabbits. Zeigler DW; Johnson JA; Koivunen DG; Siripaisarnpipat S; Fowler WL; Dostal DE; Payne CG Am J Physiol; 1986 Jul; 251(1 Pt 2):H196-204. PubMed ID: 3014904 [TBL] [Abstract][Full Text] [Related]
50. Responses of paraventricular and supraoptic units to angiotensin II, sar1-ile8-angiotensin II and hypertonic NaCl administered into the cerebral ventricle. Akaishi T; Negoro H; Kobayasi S Brain Res; 1980 Apr; 188(2):499-511. PubMed ID: 7370770 [TBL] [Abstract][Full Text] [Related]
51. Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments. Wilkes BC; Masaro L; Schiller PW; Carpenter KA J Med Chem; 2002 Sep; 45(20):4410-8. PubMed ID: 12238921 [TBL] [Abstract][Full Text] [Related]
52. Angiotensin II and [Sar1, Ile5, Ala8]angiotensin II effect on contractile activity and prostaglandin production of in vitro pregnant rat uteri. Dubin NH; Ghodgaonkar RB Endocrinology; 1980 Dec; 107(6):1855-60. PubMed ID: 7428693 [TBL] [Abstract][Full Text] [Related]
53. Cardiovascular actions of angiotensin in the fowl (Gallus domesticus). II. Angiotensin analog agonists and antagonists. Moore AF; Strong JH; Buckley JP Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):447-57. PubMed ID: 6267670 [TBL] [Abstract][Full Text] [Related]
54. Specific angiotensin II receptive neurons in the cat subfornical organ. Phillips MI; Felix D Brain Res; 1976 Jun; 109(3):531-40. PubMed ID: 1276933 [TBL] [Abstract][Full Text] [Related]
55. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat. Fernandes M; Fiorentini R; Onesti G; Bellini G; Gould AB; Hessan H; Kim KE; Swartz C Clin Sci Mol Med; 1978 Jun; 54(6):633-7. PubMed ID: 657733 [TBL] [Abstract][Full Text] [Related]
56. Hypotensive effect of [Sar1,Thr8]angiotensin II in spontaneously hypertensive sodium-depleted rats. Muñoz-Ramírez H; Khosla MC; Bumpus FM; Khairallah PA Am J Physiol; 1978 Apr; 234(4):H447-53. PubMed ID: 645884 [TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754 [TBL] [Abstract][Full Text] [Related]
58. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. Feener EP; Northrup JM; Aiello LP; King GL J Clin Invest; 1995 Mar; 95(3):1353-62. PubMed ID: 7883982 [TBL] [Abstract][Full Text] [Related]
59. Conformational restriction of angiotensin II: cyclic analogues having high potency. Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273 [TBL] [Abstract][Full Text] [Related]
60. Brain angiotensin: critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function. Harding JW; Jensen LL; Quirk WS; Dewey AL; Wright JW Peptides; 1989; 10(2):261-4. PubMed ID: 2755868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]